By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys reported late on Tuesday that revenues for the first quarter rose 66 percent.

The San Diego-based software solutions firm said that for the three months ended March 31, it posted $34.6 million in revenues, up from $20.8 million a year ago. Revenues for the quarter included $4 million in content revenue, related to databases that it acquired when it merged with Symyx during the summer. Accelrys had no content revenue in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.